Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy

Lucile Capuron, Charles L Raison, Dominique L. Musselman, David H. Lawson, Charles B. Nemeroff, Andrew H. Miller

Research output: Contribution to journalArticle

238 Citations (Scopus)

Abstract

Objective: The authors assessed the relationship between the hypothalamic-pituitary-adrenal (HPA) axis response to interferon-alpha (IFN-α) and the development of major depression during IFN-α treatment. Method: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-α therapy, both immediately before and 1, 2, and 3 hours after IFN-α administration. Symptom criteria for major depression were also evaluated at each visit. Results: ACTH and cortisol responses but not IL-6 responses to the initial administration of IFN-α were significantly higher in the seven patients who subsequently developed symptom criteria for major depression than in those who did not. No differences in hormonal or cytokine responses were found between these two groups during chronic IFN-α administration. Conclusions: The HPA axis response to the acute administration of IFN-α reveals a vulnerability to IFN-α-induced depression, possibly due to sensitization of corticotropin-releasing factor pathways.

Original languageEnglish (US)
Pages (from-to)1342-1345
Number of pages4
JournalAmerican Journal of Psychiatry
Volume160
Issue number7
DOIs
StatePublished - Jul 2003
Externally publishedYes

Fingerprint

Interferon-alpha
Injections
Therapeutics
Adrenocorticotropic Hormone
Hydrocortisone
Interleukin-6
Corticotropin-Releasing Hormone
Melanoma
Cytokines

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. / Capuron, Lucile; Raison, Charles L; Musselman, Dominique L.; Lawson, David H.; Nemeroff, Charles B.; Miller, Andrew H.

In: American Journal of Psychiatry, Vol. 160, No. 7, 07.2003, p. 1342-1345.

Research output: Contribution to journalArticle

Capuron, Lucile ; Raison, Charles L ; Musselman, Dominique L. ; Lawson, David H. ; Nemeroff, Charles B. ; Miller, Andrew H. / Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. In: American Journal of Psychiatry. 2003 ; Vol. 160, No. 7. pp. 1342-1345.
@article{eb35fc7f704847fa975ba5ebb5be1c99,
title = "Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy",
abstract = "Objective: The authors assessed the relationship between the hypothalamic-pituitary-adrenal (HPA) axis response to interferon-alpha (IFN-α) and the development of major depression during IFN-α treatment. Method: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-α therapy, both immediately before and 1, 2, and 3 hours after IFN-α administration. Symptom criteria for major depression were also evaluated at each visit. Results: ACTH and cortisol responses but not IL-6 responses to the initial administration of IFN-α were significantly higher in the seven patients who subsequently developed symptom criteria for major depression than in those who did not. No differences in hormonal or cytokine responses were found between these two groups during chronic IFN-α administration. Conclusions: The HPA axis response to the acute administration of IFN-α reveals a vulnerability to IFN-α-induced depression, possibly due to sensitization of corticotropin-releasing factor pathways.",
author = "Lucile Capuron and Raison, {Charles L} and Musselman, {Dominique L.} and Lawson, {David H.} and Nemeroff, {Charles B.} and Miller, {Andrew H.}",
year = "2003",
month = "7",
doi = "10.1176/appi.ajp.160.7.1342",
language = "English (US)",
volume = "160",
pages = "1342--1345",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "7",

}

TY - JOUR

T1 - Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy

AU - Capuron, Lucile

AU - Raison, Charles L

AU - Musselman, Dominique L.

AU - Lawson, David H.

AU - Nemeroff, Charles B.

AU - Miller, Andrew H.

PY - 2003/7

Y1 - 2003/7

N2 - Objective: The authors assessed the relationship between the hypothalamic-pituitary-adrenal (HPA) axis response to interferon-alpha (IFN-α) and the development of major depression during IFN-α treatment. Method: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-α therapy, both immediately before and 1, 2, and 3 hours after IFN-α administration. Symptom criteria for major depression were also evaluated at each visit. Results: ACTH and cortisol responses but not IL-6 responses to the initial administration of IFN-α were significantly higher in the seven patients who subsequently developed symptom criteria for major depression than in those who did not. No differences in hormonal or cytokine responses were found between these two groups during chronic IFN-α administration. Conclusions: The HPA axis response to the acute administration of IFN-α reveals a vulnerability to IFN-α-induced depression, possibly due to sensitization of corticotropin-releasing factor pathways.

AB - Objective: The authors assessed the relationship between the hypothalamic-pituitary-adrenal (HPA) axis response to interferon-alpha (IFN-α) and the development of major depression during IFN-α treatment. Method: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-α therapy, both immediately before and 1, 2, and 3 hours after IFN-α administration. Symptom criteria for major depression were also evaluated at each visit. Results: ACTH and cortisol responses but not IL-6 responses to the initial administration of IFN-α were significantly higher in the seven patients who subsequently developed symptom criteria for major depression than in those who did not. No differences in hormonal or cytokine responses were found between these two groups during chronic IFN-α administration. Conclusions: The HPA axis response to the acute administration of IFN-α reveals a vulnerability to IFN-α-induced depression, possibly due to sensitization of corticotropin-releasing factor pathways.

UR - http://www.scopus.com/inward/record.url?scp=0042477750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042477750&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.160.7.1342

DO - 10.1176/appi.ajp.160.7.1342

M3 - Article

C2 - 12832253

AN - SCOPUS:0042477750

VL - 160

SP - 1342

EP - 1345

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 7

ER -